Challenges and complications of poly (lactic-co-glycolic acid)-based long-acting drug product development
Poly(lactic-co-glycolic acid) (PLGA) is one of the preferred polymeric inactive ingredients for long-acting parenteral drug products that are constituted of complex formulations. Despite over 30 years of use, there are still many challenges faced by researchers in formulation-related aspects pertain...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
MDPI
2022
|
| _version_ | 1825938410650468352 |
|---|---|
| author | Lim, Yi Wen Tan, Wen Siang Ho, Kok Lian Mariatulqabtiah, Abdul Razak Abu Kasim, Noor Hayaty Abd. Rahman, Noorsaadah Wong, Tin Wui Chee, Chin Fei Chee |
| author_facet | Lim, Yi Wen Tan, Wen Siang Ho, Kok Lian Mariatulqabtiah, Abdul Razak Abu Kasim, Noor Hayaty Abd. Rahman, Noorsaadah Wong, Tin Wui Chee, Chin Fei Chee |
| author_sort | Lim, Yi Wen |
| collection | UPM |
| description | Poly(lactic-co-glycolic acid) (PLGA) is one of the preferred polymeric inactive ingredients for long-acting parenteral drug products that are constituted of complex formulations. Despite over 30 years of use, there are still many challenges faced by researchers in formulation-related aspects pertaining to drug loading and release. Until now, PLGA-based complex generic drug products have not been successfully developed. The complexity in developing these generic drug products is not just due to their complex formulation, but also to the manufacturing process of the listed reference drugs that involve PLGA. The composition and product attributes of commercial PLGA formulations vary with the drugs and their intended applications. The lack of standard compendial methods for in vitro release studies hinders generic pharmaceutical companies in their efforts to develop PLGA-based complex generic drug products. In this review, we discuss the challenges faced in developing PLGA-based long-acting injectable/implantable (LAI) drug products; hurdles that are associated with drug loading and release that are dictated by the physicochemical properties of PLGA and product manufacturing processes. Approaches to overcome these challenges and hurdles are highlighted specifically with respect to drug encapsulation and release. |
| first_indexed | 2024-03-06T11:13:27Z |
| format | Article |
| id | upm.eprints-100651 |
| institution | Universiti Putra Malaysia |
| last_indexed | 2024-03-06T11:13:27Z |
| publishDate | 2022 |
| publisher | MDPI |
| record_format | dspace |
| spelling | upm.eprints-1006512023-09-21T08:05:33Z http://psasir.upm.edu.my/id/eprint/100651/ Challenges and complications of poly (lactic-co-glycolic acid)-based long-acting drug product development Lim, Yi Wen Tan, Wen Siang Ho, Kok Lian Mariatulqabtiah, Abdul Razak Abu Kasim, Noor Hayaty Abd. Rahman, Noorsaadah Wong, Tin Wui Chee, Chin Fei Chee Poly(lactic-co-glycolic acid) (PLGA) is one of the preferred polymeric inactive ingredients for long-acting parenteral drug products that are constituted of complex formulations. Despite over 30 years of use, there are still many challenges faced by researchers in formulation-related aspects pertaining to drug loading and release. Until now, PLGA-based complex generic drug products have not been successfully developed. The complexity in developing these generic drug products is not just due to their complex formulation, but also to the manufacturing process of the listed reference drugs that involve PLGA. The composition and product attributes of commercial PLGA formulations vary with the drugs and their intended applications. The lack of standard compendial methods for in vitro release studies hinders generic pharmaceutical companies in their efforts to develop PLGA-based complex generic drug products. In this review, we discuss the challenges faced in developing PLGA-based long-acting injectable/implantable (LAI) drug products; hurdles that are associated with drug loading and release that are dictated by the physicochemical properties of PLGA and product manufacturing processes. Approaches to overcome these challenges and hurdles are highlighted specifically with respect to drug encapsulation and release. MDPI 2022-03 Article PeerReviewed Lim, Yi Wen and Tan, Wen Siang and Ho, Kok Lian and Mariatulqabtiah, Abdul Razak and Abu Kasim, Noor Hayaty and Abd. Rahman, Noorsaadah and Wong, Tin Wui and Chee, Chin Fei Chee (2022) Challenges and complications of poly (lactic-co-glycolic acid)-based long-acting drug product development. Pharmaceutics, 14 (3). art. no. 614. pp. 1-21. ISSN 1999-4923 https://www.mdpi.com/1999-4923/14/3/614 10.3390/pharmaceutics14030614 |
| spellingShingle | Lim, Yi Wen Tan, Wen Siang Ho, Kok Lian Mariatulqabtiah, Abdul Razak Abu Kasim, Noor Hayaty Abd. Rahman, Noorsaadah Wong, Tin Wui Chee, Chin Fei Chee Challenges and complications of poly (lactic-co-glycolic acid)-based long-acting drug product development |
| title | Challenges and complications of poly (lactic-co-glycolic acid)-based long-acting drug product development |
| title_full | Challenges and complications of poly (lactic-co-glycolic acid)-based long-acting drug product development |
| title_fullStr | Challenges and complications of poly (lactic-co-glycolic acid)-based long-acting drug product development |
| title_full_unstemmed | Challenges and complications of poly (lactic-co-glycolic acid)-based long-acting drug product development |
| title_short | Challenges and complications of poly (lactic-co-glycolic acid)-based long-acting drug product development |
| title_sort | challenges and complications of poly lactic co glycolic acid based long acting drug product development |
| work_keys_str_mv | AT limyiwen challengesandcomplicationsofpolylacticcoglycolicacidbasedlongactingdrugproductdevelopment AT tanwensiang challengesandcomplicationsofpolylacticcoglycolicacidbasedlongactingdrugproductdevelopment AT hokoklian challengesandcomplicationsofpolylacticcoglycolicacidbasedlongactingdrugproductdevelopment AT mariatulqabtiahabdulrazak challengesandcomplicationsofpolylacticcoglycolicacidbasedlongactingdrugproductdevelopment AT abukasimnoorhayaty challengesandcomplicationsofpolylacticcoglycolicacidbasedlongactingdrugproductdevelopment AT abdrahmannoorsaadah challengesandcomplicationsofpolylacticcoglycolicacidbasedlongactingdrugproductdevelopment AT wongtinwui challengesandcomplicationsofpolylacticcoglycolicacidbasedlongactingdrugproductdevelopment AT cheechinfeichee challengesandcomplicationsofpolylacticcoglycolicacidbasedlongactingdrugproductdevelopment |